FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090671106> ?p ?o ?g. }

• W2090671106 endingPage "945" @default.
• W2090671106 startingPage "937" @default.
• W2090671106 abstract "Objectives: To evaluate the role of highly active antiretroviral therapy and chemotherapy on tumor response among persons with AIDS-related Kaposi sarcoma and identify factors associated with response in a clinic setting. Design: Retrospective cohort. Methods: One hundred and fourteen patients from two HIV clinics with a diagnosis of Kaposi sarcoma were identified via a clinical database. Records were reviewed to confirm Kaposi sarcoma diagnosis and abstract clinical and chemotherapy information. Demographics, laboratory values, and highly active antiretroviral therapy use were abstracted electronically. Cox's proportional hazards models identified predictors of Kaposi sarcoma improvement and resolution. Results: Thirty-six months following Kaposi sarcoma diagnosis, the rate of improvement among 64 patients with confirmed Kaposi sarcoma was 77% and that of complete resolution was 51%. In univariate analyses, recent chemotherapy was associated with Kaposi sarcoma improvement, and recent HIV viral load and highly active antiretroviral therapy were associated with both improvement and resolution. No measured baseline characteristics (tumor stage, diagnosis year, CD4 T-cell count, HIV viral load, or prior highly active antiretroviral therapy history) or recent CD4 T-cell counts predicted improvement or resolution. In multivariate analyses, recent chemotherapy (hazard ratio 5.5, 95% confidence interval: 2.7–11.2, P < 0.001) and highly active antiretroviral therapy (hazard ratio 4.1, 95% confidence interval: 1.4–12.6, P = 0.01) were predictors of improvement; only recent highly active antiretroviral therapy was associated with resolution (hazard ratio 6.2, 95% confidence interval: 1.5–26.4, P = 0.01). Response was not associated with type of highly active antiretroviral therapy regimen (non nucleoside reverse transcriptase inhibitor based, protease inhibitor based, or ritonavir-boosted protease inhibitor based). Conclusion: Highly active antiretroviral therapy and chemotherapy are important in clinical Kaposi sarcoma response. Despite widespread availability of these therapies, Kaposi sarcoma continues to be a clinical problem; only half the patients achieved complete resolution of disease. New therapeutic approaches are needed." @default.
• W2090671106 created "2016-06-24" @default.
• W2090671106 creator A5022484957 @default.
• W2090671106 creator A5052928140 @default.
• W2090671106 creator A5058728247 @default.
• W2090671106 creator A5077239845 @default.
• W2090671106 creator A5084651750 @default.
• W2090671106 creator A5085370688 @default.
• W2090671106 date "2008-05-11" @default.
• W2090671106 modified "2023-10-02" @default.
• W2090671106 title "Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response" @default.
• W2090671106 cites W1791637602 @default.
• W2090671106 cites W1918322381 @default.
• W2090671106 cites W1930190979 @default.
• W2090671106 cites W1962493215 @default.
• W2090671106 cites W1965034476 @default.
• W2090671106 cites W1965541995 @default.
• W2090671106 cites W1970202484 @default.
• W2090671106 cites W1992192692 @default.
• W2090671106 cites W1999339667 @default.
• W2090671106 cites W2001882485 @default.
• W2090671106 cites W2008557562 @default.
• W2090671106 cites W2009008912 @default.
• W2090671106 cites W2020830322 @default.
• W2090671106 cites W2022636965 @default.
• W2090671106 cites W2027744948 @default.
• W2090671106 cites W2028713865 @default.
• W2090671106 cites W2029636881 @default.
• W2090671106 cites W2037976026 @default.
• W2090671106 cites W2038198483 @default.
• W2090671106 cites W2041052618 @default.
• W2090671106 cites W2044113923 @default.
• W2090671106 cites W2045121497 @default.
• W2090671106 cites W2051521205 @default.
• W2090671106 cites W2058069863 @default.
• W2090671106 cites W2059136727 @default.
• W2090671106 cites W2061178459 @default.
• W2090671106 cites W2063611994 @default.
• W2090671106 cites W2066250170 @default.
• W2090671106 cites W2069786905 @default.
• W2090671106 cites W2081258495 @default.
• W2090671106 cites W2085140598 @default.
• W2090671106 cites W2098743753 @default.
• W2090671106 cites W2105288306 @default.
• W2090671106 cites W2106016270 @default.
• W2090671106 cites W2108089761 @default.
• W2090671106 cites W2116267021 @default.
• W2090671106 cites W2120107087 @default.
• W2090671106 cites W2137116680 @default.
• W2090671106 cites W2140522681 @default.
• W2090671106 cites W2143795959 @default.
• W2090671106 cites W2144365452 @default.
• W2090671106 cites W2145365367 @default.
• W2090671106 cites W2149870649 @default.
• W2090671106 cites W2157635632 @default.
• W2090671106 cites W2163827242 @default.
• W2090671106 cites W2165837635 @default.
• W2090671106 cites W2171127982 @default.
• W2090671106 cites W2317488314 @default.
• W2090671106 cites W2328569468 @default.
• W2090671106 cites W4254613993 @default.
• W2090671106 doi "https://doi.org/10.1097/qad.0b013e3282ff6275" @default.
• W2090671106 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2730951" @default.
• W2090671106 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18453853" @default.
• W2090671106 hasPublicationYear "2008" @default.
• W2090671106 type Work @default.
• W2090671106 sameAs 2090671106 @default.
• W2090671106 citedByCount "108" @default.
• W2090671106 countsByYear W20906711062012 @default.
• W2090671106 countsByYear W20906711062013 @default.
• W2090671106 countsByYear W20906711062014 @default.
• W2090671106 countsByYear W20906711062015 @default.
• W2090671106 countsByYear W20906711062016 @default.
• W2090671106 countsByYear W20906711062017 @default.
• W2090671106 countsByYear W20906711062018 @default.
• W2090671106 countsByYear W20906711062019 @default.
• W2090671106 countsByYear W20906711062020 @default.
• W2090671106 countsByYear W20906711062021 @default.
• W2090671106 countsByYear W20906711062022 @default.
• W2090671106 countsByYear W20906711062023 @default.
• W2090671106 crossrefType "journal-article" @default.
• W2090671106 hasAuthorship W2090671106A5022484957 @default.
• W2090671106 hasAuthorship W2090671106A5052928140 @default.
• W2090671106 hasAuthorship W2090671106A5058728247 @default.
• W2090671106 hasAuthorship W2090671106A5077239845 @default.
• W2090671106 hasAuthorship W2090671106A5084651750 @default.
• W2090671106 hasAuthorship W2090671106A5085370688 @default.
• W2090671106 hasBestOaLocation W20906711061 @default.
• W2090671106 hasConcept C126322002 @default.
• W2090671106 hasConcept C141071460 @default.
• W2090671106 hasConcept C142462285 @default.
• W2090671106 hasConcept C142724271 @default.
• W2090671106 hasConcept C143998085 @default.
• W2090671106 hasConcept C167135981 @default.
• W2090671106 hasConcept C203014093 @default.
• W2090671106 hasConcept C207103383 @default.
• W2090671106 hasConcept C2776694085 @default.
• W2090671106 hasConcept C2778256501 @default.

• next